Victory Capital Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,707
| Closed | -$32.2K | – | 2509 |
|
|
2025
Q1 | $32.2K | Sell |
10,707
-9,061
| -46% | -$27.3K | ﹤0.01% | 2397 |
|
|
2024
Q4 | $50.6K | Buy |
19,768
+8
| +0% | +$20 | ﹤0.01% | 2394 |
|
|
2024
Q3 | $73.5K | Sell |
19,760
-193
| -1% | -$718 | ﹤0.01% | 2356 |
|
|
2024
Q2 | $126K | Buy |
19,953
+2,746
| +16% | +$17.4K | ﹤0.01% | 2267 |
|
|
2024
Q1 | $92.4K | Sell |
17,207
-435
| -2% | -$2.34K | ﹤0.01% | 2314 |
|
|
2023
Q4 | $88.6K | Buy |
17,642
+3,613
| +26% | +$18.1K | ﹤0.01% | 2365 |
|
|
2023
Q3 | $23.7K | Buy |
+14,029
| New | +$23.7K | ﹤0.01% | 2438 |
|
|
2022
Q3 | – | Sell |
-11,741
| Closed | -$44K | – | 2731 |
|
|
2022
Q2 | $44K | Sell |
11,741
-75
| -0.6% | -$281 | ﹤0.01% | 2561 |
|
|
2022
Q1 | $43K | Buy |
11,816
+248
| +2% | +$903 | ﹤0.01% | 2607 |
|
|
2021
Q4 | $70K | Sell |
11,568
-13,890
| -55% | -$84.1K | ﹤0.01% | 2621 |
|
|
2021
Q3 | $248K | Buy |
25,458
+1,033
| +4% | +$10.1K | ﹤0.01% | 2446 |
|
|
2021
Q2 | $349K | Sell |
24,425
-11,228
| -31% | -$160K | ﹤0.01% | 2363 |
|
|
2021
Q1 | $846K | Buy |
35,653
+4,098
| +13% | +$97.2K | ﹤0.01% | 1982 |
|
|
2020
Q4 | $421K | Buy |
+31,555
| New | +$421K | ﹤0.01% | 2157 |
|
|
2020
Q2 | – | Sell |
-11,246
| Closed | -$32K | – | 2850 |
|
|
2020
Q1 | $32K | Buy |
+11,246
| New | +$32K | ﹤0.01% | 2934 |
|
|
2019
Q4 | – | Sell |
-9,415
| Closed | -$11K | – | 2916 |
|
|
2019
Q3 | $11K | Buy |
+9,415
| New | +$11K | ﹤0.01% | 3227 |
|